Skip to content
CANCER RESOURCES & SUPPORT
The Sarah Cannon Cancer Blog
developed in collaboration with our Sarah Cannon experts
BROWSE THE BLOG
Melanoma: What You Should Know
Melanoma: What You Should Know

Meredith McKean, MD, MPH, Associate Director, Melanoma and Skin Cancer Research, Sarah Cannon Research Institute, shares what you should know about melanoma, including ways to help lower your risk and the advancements in the treatment of melanoma.  If you have questions about melanoma, call askSARAH now at (844) 482-4812 to speak to a nurse who is specially trained […]

Read More
Five Things to Know About Testicular Cancer
Five Things to Know About Testicular Cancer

Though rare, it is important for all men to learn about testicular cancer and know what to look for should they experience any concerning symptoms. Testicular cancer is highly treatable and usually able to be removed completely upon detection. According to American Cancer Society, there is a 99 percent survival rate for testicular cancer diagnosed […]

Read More
Signs and Symptoms of Testicular Cancer
Signs and Symptoms of Testicular Cancer

Testicular cancer itself is relatively rare, estimated to represent half of one percent of all new cancer cases in the United States. It’s also highly treatable, and, according to  the 5-year survival for localized testicular cancer is 99%. The key to survival of this disease is early detection and treatment. Testicular Cancer Risk Factors It’s important […]

Read More
4 Ways Prostate Cancer & Testicular Cancer are Different
4 Ways Prostate Cancer & Testicular Cancer are Different

Although the prostate and the testicles are both part of the male reproductive system, prostate cancer and testicular cancer are different from one another. Here is how: 1. Where the cancer starts Testicular cancer and prostate cancer are different because the cancer starts in different places in the body. Prostate cancer occurs when cancer begins […]

Read More
“Watchful Waiting”… What Is It?
“Watchful Waiting”… What Is It?

Research has shown that for patients with chronic lymphocytic leukemia (CLL), whose disease is not acting aggressively, immediate treatment is not always the best approach. This may seem confusing or concerning for patients and their families who want to begin treatment as quickly as possible. Experts from the Sarah Cannon Transplant and Cellular Therapy Network […]

Read More
More Resources